Germin8 Ventures is a multi-stage venture capital firm based in Chicago, investing in disruptive Food & AgTech companies across the value chain. The firm focuses on breakthrough technologies at the intersection of agriculture, food, and life sciences, with an emphasis on 'food as medicine' and frontier science innovations.
56% of their portfolio is in Food & Agriculture. Average disclosed round size is $30.0M (across 8 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
ML
Michael Lavin
Managing Partner
AL
Ashlie L Burkart MD, CM
Investor
CH
Charles Holmes
Investor
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Matterworks | Series A | — | Jun 2025 |
 Kanvas Biosciences | Series A | $12.5M | Jul 2024 |
| CCropX Inc. | Series C | $30M | Jan 2023 |
 AgriWebb | Series B | $6.8M | Oct 2022 |
 Nobell Foods | Series B | $75M | Jul 2021 |
 Fieldin | Seed | $4M | Jan 2018 |
 Avalo | Series A | $11M | — |
 Nobell | Series B | $75M | — |
 Bushel | Unknown | $26M | — |
Top Co-Investors
GL Ventures3 shared
Fifty Years2 shared
Andreessen Horowitz2 shared
AgFunder2 shared
FootPrint Coalition2 shared
Breakthrough Energy Ventures2 shared
Pear VC2 shared
Panacea Venture1 shared
DCVC1 shared
W Health Ventures1 shared
Terra Venture Partners1 shared
OKX Ventures1 shared
Intermountain Health1 shared
Pillar VC1 shared
Tarsadia Capital1 shared
iSelect Fund1 shared
Y Combinator1 shared
Greycroft1 shared
Lewis & Clark AgriFood1 shared
Continental Grain Company1 shared
Last updated: 8 September 2026